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INTRODUCTION 
 
The aging process is characterized by the loss of several 
physiological functions that can lead to diseases [1]. 
Among these processes, energy balance control stands 
out, given its role in obesity and metabolic syndromes. 
It has been demonstrated that aging is related to 
hyperphagia, a reduction in energy expenditure and 
increased adiposity in humans and rodents [2-6]. 
Moreover, brown adipose tissue (BAT) mass appears to 
decline in human males during aging [7]. BAT is 
responsible for controlling thermogenesis and energy 
expenditure through heat production by an uncoupling 
protein, UCP1 [8]. Defects in UCP1 expression can 
cause defective thermogenic response, weight gain and 
metabolic syndrome. In addition, several experimental 
studies have shown that disruption of hypothalamic 
function during aging is associated with a reduction in 
the expression of neuroendocrine hormones, resulting in 
obesity, defective thermogenic responses, an increased 
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ABSTRACT 
 
Recently, we demonstrated that the hypothalamic S1PR1/STAT3 axis plays a critical role in the control of food 
consumption and energy expenditure in rodents. Here, we found that reduction of hypothalamic S1PR1 
expression occurs in an age-dependent manner, and was associated with defective thermogenic signaling and 
weight gain. To address the physiological relevance of these findings, we investigated the effects of chronic and 
acute exercise on the hypothalamic S1PR1/STAT3 axis. Chronic exercise increased S1PR1 expression and STAT3 
phosphorylation in the hypothalamus, restoring the anorexigenic and thermogenic signals in middle-aged mice. 
Acutely, exercise increased sphingosine-1-phosphate (S1P) levels in the cerebrospinal fluid (CSF) of young rats, 
whereas the administration of CSF from exercised young rats into the hypothalamus of middle-aged rats at rest 
was sufficient to reduce the food intake. Finally, the intracerebroventricular (ICV) administration of S1PR1 
activators, including the bioactive lipid molecule S1P, and pharmacological S1PR1 activator, SEW2871, induced 
a potent STAT3 phosphorylation and anorexigenic response in middle-aged rats. Overall, these results suggest 
that hypothalamic S1PR1 is important for the maintenance of energy balance and provide new insights into the 
mechanism by which exercise controls the anorexigenic and thermogenic signals in the central nervous system 
during the aging process. 
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incidence of age-related pathologies, and a reduction in 
the lifespan of rodents [9-12].  
 
Currently, it has been described that the sphingine-1-
phosphate (S1P), a bioactive sphingolipids, is related to 
cell death as cell migration, proliferation, apoptosis, 
necrosis and cancer [13-15]. The S1P have five 
receptors (S1PR1-5) where each receptor has different 
functions in different tissues [14]. In particular, the 
S1PR1 receptor, also called EDG1, it has been 
highlighted that some S1PR1 functions require STAT3 
protein. The S1P/S1PR1/STAT3 axis controls the 
development of several cancer type [16-20]. We 
described the role of hypothalamic sphingosine-1-
phosphate receptor 1 (S1PR1) in the control of energy 
homeostasis through the Jak/STAT signaling and 
melanocortin systems in rodents [21]. We reported that 
neuronal S1P/S1PR1/STAT3 signaling plays an 
important role in distinct conditions of abnormal 
feeding behavior, such as obesity and cancer-induced 
anorexia [21]. The bioactive lipid, sphingosine-1-
phosphate (S1P), can activate STAT3 in specific 
hypothalamic nuclei that control the anorexigenic and 
thermogenic signals in rodents [21]. 
 
Once the physical exercise increases the S1P in plasma 
levels in humans [22] and also in the muscle [23-25] it 
seems to be a potent therapeutic target in controlling the 
maintenance of body weight, food consumption, fat 
mass and thermogenesis [26-34]. Interestingly, physical 
exercise also induces upregulation of S1PR1, S1PR2 
and S1PR3 in skeletal muscle of rats [25]. Based on 
these data we hypothesized that defective thermogenic 
signal and excessive food consumption frequently 
observed during aging could be, at least in part, 
associated with the impairment of hypothalamic 
S1PR1/STAT3 signaling. In addition, we sought to 
determine the effects of physical exercise on the 
S1P/S1PR1/STAT3 axis in the hypothalamus of middle-
age rodents.  
 
Figure 1. Characterization of phenotypic and evaluation of S1PR1/STAT3 axis in middle-aged mice.  Body weight (a) (n=8 
per group) and epididymal fat (b) (n=7 per group). UCP1 mRNA levels (c) and coloration of BAT (d) (n=7–10 per group). The Clams 
equipment was used to determinate VO2 (e), VCO2 (f), RER (g), and ambulatory activity point to point during 12 hours in light and dark 
period (h) and mean of cycle light and dark (i) (n=8 per group). Western blots showing S1PR1 protein levels and STAT3 tyrosine 
phosphorylation (j) in the hypothalamus of young and middle-aged mice. The mice were fasted prior to hypothalamus extraction for 10 
hours (n= 6 per group). The Student’s t-test was performed to evaluate data. ± SEM are shown in (a and f) ***p<.0001; (c) **p<0,0021; 
(b,e and g) *p<0.05. For ambulatory activity point to point, as determined by Student´s t-test where (h) *p<0.05.  
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RESULTS 
 
Impairment of the hypothalamic S1PR1/STAT3 axis 
in middle-aged mice. 
 
First, we sought to determine the pattern of food 
consumption, body composition, energy expenditure 
and S1PR1/STAT3 signaling in the hypothalamus of 
young and middle-aged mice. The results revealed that 
middle-aged mice have higher body weight and 
epididymal fat (Fig. 1a, b), decreased UCP1 gene 
expression (Fig. 1c) and change in the color of BAT 
(Fig. 1d). In addition, we observed the reduction of 
consumption VO2, production CO2 and respiratory 
exchange ratio (RER) (VCO2/VO2) (Fig. 1e, f, g) during 
the dark cycle when compared to younger group. 
However, ambulatory activity was slightly higher in the 
middle-aged mice at some points of the dark cycle, 
when compared to the younger group (Fig. 1h), but no 
difference was observed when compared to the average 
of each group (Fig. 1i). Interestingly, these findings 
were accompanied by a strong reduction of S1PR1 
 
 
Figure 2. Effects of chronic exercise in the hypothalamus of middle-aged mice.  Experimental design (a).Body weight curve 
(b). Dual energy X-ray absorptiometry analyses was performed to evaluate: area (c), body weight variation (d), fat mass variation (e) 
(n=3 per group). Cumulative food consumption (f), mean of food intake (g) (n=11 per group). Clams equipment were used to monitor: 
O2 consumption (h), CO2 production (i), heat rate (j) and ambulatory activity hours for hours during light and dark periods (k) and the 
mean ambulatory (l) in middle-aged exercised and at rest groups (n=3–4 per group). Analyses were made after the last day of training. 
Western blots of UCP1 protein levels in BAT (m); as well S1PR1 expression and STAT3 phosphorylation in the hypothalamus (n) (n=6 per 
group). The Student’s t-test was performed to evaluate data.  ± SEM are shown in (e) **p<0.0017; (g) ***p<0.0001; (c,d,h,i and j) 
*p<0.05. For body weight, cumulative food intake and ambulatory activity point to point, as determined by Student´s t-test where (b) 
*p<0.05, **p<0.01 and ***p<0.001, (f) *p<0.05, **p<0.01, (k) **p<0.01.  
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protein levels in the hypothalamus of middle-aged mice 
when compare to the younger mice. A similar profile 
was observed in STAT3 phosphorylation (Fig. 1j). 
These data suggest that hypothalamic S1PR1 signaling 
could be involved in the control of energy homeostasis 
during aging. 
 
Chronic exercise increases S1PR1 in the 
hypothalamus of middle-aged mice.  
 
Next, we sought to determine the effects of exercise in 
the control of S1PR1 signaling in the hypothalamus of 
middle-aged mice. To address this issue, middle-aged 
mice were submitted to a chronic exercise 
(experimental design, Fig. 2a), thereafter we evaluated 
S1PR1/STAT3 and UCP-1 protein signaling, and 
monitored food intake, body weight and energy 
expenditure. First we evaluated the body weight gain 
between middle-aged mice at rest and exercised animals 
(Fig. 2b). The Dual energy X-ray absorptiometry (DXA 
scan) analysis revealed that exercise reduced total body 
area (Fig. 2c), total body weight (Fig. 2d), and fat mass 
(Fig. 2e). No difference was found in bone mineral 
density (suppl. 1a).  
 
Next we analyzed cumulative food consumption and 
observed a difference between the groups after the 
second week of training (Fig. 2f); mean daily food 
intake was lower in the exercised group (Fig. 2g). The 
chronic exercise increased energy expenditure, through 
the increase of O2 consumption (Fig. 2h), release of 
CO2 (Fig. 2i) and increased heat rate (Fig. 2j). During 
some points of the dark period, the ambulatory activity 
was significantly higher in the resting group when 
compared to exercised group (Fig. 2k). We also 
observed higher ambulatory activity in the resting group 
during the light cycle when compared to the exercised 
group (Fig. 2l).  
 
Next, we evaluated the BAT and hypothalamus from 
exercised and sedentary middle-aged mice. Western 
blot analyses showed an increase of UCP1 protein 
levels in the BAT of exercised mice when compared to 
rest group (Fig. 2m), confirming that higher energy 
expenditure occurs in trained mice, as observed. 
Hypothalamic samples revealed that chronic exercise 
increased S1PR1 protein levels and STAT3 
phosphorylation (Fig. 2n) in the exercised group when 
compared to resting group.  
 
Since interleukin-6 (IL-6) mediates some anorexigenic 
and thermogenic responses in the hypothalamus of 
exercised rodents20, we monitored IL-6 serum levels in 
exercised and sedentary mice. The serum analysis of IL-
6 demonstrated high levels of IL-6 in middle-aged mice 
when compared to the younger group and the physical 
 
Figure 3. Evaluation of S1PR1/STAT3 axis in the hypothalamus of middle-aged rats.  Body weight (a) (n=6–8 per group) 
and epididymal fat pad weight (b) (n=5 per group). Image of BAT (n=6 per group) (c). Representative Western blots show: UCP1 
expression (d) S1PR1 protein expression and STAT3 tyrosine phosphorylation in hypothalamus (e) in young and middle-aged rats. 
Rats were fasted for 10 hours prior to extraction of the hypothalamus for Western blots analysis (n=6 per group). The Student’s t-
test was performed to evaluate data. means ± SEM are shown in (a) ***p<0.0001 to (b) ***p<0.0005. 
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training appeared to reduce the serum levels of this 
cytokine (suppl. 1b). Collectively, these data 
demonstrate that the defective anorexigenic and 
thermogenic signaling observed during aging could be, 
at least in part, associated with the down-regulation of 
hypothalamic S1PR1/STAT3 signaling and the 
chronical exercise can restore this axis. 
 
The S1PR1/STAT3 axis is suppressed in the 
hypothalamus of middle-aged rats.  
 
To confirm our preliminary data, we used another 
animal model. We evaluated the food intake, body 
weight, adiposity, BAT and hypothalamus of middle-
aged and young Wistar rats. While middle-aged rats 
displayed higher body weight (Fig. 3a) and epididymal 
fat (Fig. 3b) compared to younger group, these rats 
presented alteration in color of the BAT (Fig. 3c) with 
low protein levels of UCP1 in this tissue (Fig. 3d). 
Interestingly, these data were accompanied by low 
levels of S1PR1 expression and STAT3 
phosphorylation in the hypothalamus (Fig. 3e). We also 
compared S1PR1 protein levels and STAT3 
phosphorylation in the hypothalamus of middle-aged 
old rats with those of an advanced age (24 months). We 
observed a slight reduction of hypothalamic S1PR1 
protein in the older rats when compared to middle-aged 
group, but no difference was observed in the 
S1PR1/STAT3 phosphorylation between these groups 
(suppl. 2a).  
 
 
Figure 4. Acute exercise improves S1PR1/STAT3 in the hypothalamus of rats.  Experimental design (a). Single and double-
immunostaining was performed to evaluate the co-localization of S1PR1 (green) with STAT3 phosphorylation and POMC (red) in the 
third ventricle young, Middle-Aged and Middle-Aged exercised of rats (b). The hypothalamic extraction for analysis was made 3 hours 
after the acute protocol exercise. Food intake over 12 hours (c) (n= 8 per group). Hypothalamic NPY mRNA levels (d) (n=6–7 per group). 
Western blot showing S1PR1 expression and STAT3 phosphorylation (e) in the hypothalamus of middle-aged vs. middle-aged exercised 
(n=6 per group). UCP1 mRNA levels in BAT (f) (n=6 per group). Western blot showing UCP1 expression in BAT (g) and Image of BAT (n=6 
per group) (h). The samples of hypothalamus and BAT were extracted after three hours of exercise. The Student’s t-test was performed 
where (c) ***p<0.0003, (d) **p<0.0026 and (f) *p<0.0123.  
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The hypothalamic S1PR1/STAT3 axis is activated by 
acute exercise.  
 
Next, we sought to investigate the effect of acute 
exercise on hypothalamic S1PR1/STAT3/POMC 
signaling in middle-aged rats (experimental design, Fig. 
4a). Initially, we analyzed the relationship hypothalamic 
neuronal about the S1PR1 receptor between the STAT3 
phosphorylation and anorexigenic POMC neuronal in 
the third ventricle on young, Middle-Aged and Middle-
Aged exercised. The results showed interaction between 
these molecules (Fig. 4b). Next, our results showed that 
acute exercise reduced food consumption in middle-
aged rats (Fig. 4c), which was accompanied by a 
reduction of neuropeptide Y (NPY) mRNA levels in the 
hypothalamus (Fig. 4d). Notably, prolonged, acute 
exercise was able to increase S1PR1 protein levels and 
STAT3 phosphorylation in the hypothalamus (Fig. 4e) 
in addition to increasing levels of UCP1 mRNA and its 
coding protein (Fig. 4f and g). BAT coloration was 
changed (Fig. 4h). There was no change in total body 
weight or epididymal fat pad weight between these 
groups (data not shown). 
 
Importantly, the serum level of IL-6 was higher in 
middle-aged rats when compared to the young group, 
 
Figure 5. Anorexigenic effects of hypothalamic S1PR1 activation in middle-aged rats. 12 hours of food consumption after 
ICV injection of S1P (50 ng) (a) or SEW2871 (50 nM) (b) (n=5–6 per group), as analyzed by Student’s t-test. Western blot showing, 
STAT3tyr705 and AKTser473 phosphorylation in hypothalamic samples of Wistar rats 30 minutes after S1P injection (c) (n=6 per group). 
Western blot showing STAT3tyr705 phosphorylation. The samples were obtained 30 minutes after ICV SEW2871 injection (d) (n=6 per 
group). S1P levels (µM) of CSF in young rats at rest and after acute exercise, as analysed by Student’s t-test (e) (n=5 per group). 
Food intake (f) for 12 hours in middle-aged rats after ICV injection of CSF (2 µL) from young rats at rest and from young exercised 
rats in middle-aged rats (n=6–7 per group). The Student’s t-test where (a) *p<0.0229, (b) **p<0.0022, (e) ***p<0.0006.  One-way 
ANOVA was used to (f) *** p<0.0001 vs ICV Saline Middle-Aged and ICV CSF Young Rest; *p<0.05 vs ICV CSF Young Exercised ---
Middle-Aged. 
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but a single session of acute exercise was not enough to 
increase significantly the serum levels of IL-6 in this 
experimental group (suppl. 3a).  
 
Hypothalamic stimulation of S1PR1/STAT3 
signaling reduces food intake in middle-aged rats.  
 
To determine if specific stimulation of S1PR1 in the 
hypothalamus modulates energy homeostasis in middle-
aged rats, we performed an acute intracerebroventricular 
(ICV) injection of two different S1PR1 agonists. We 
observed that both agonists, S1P and SEW2871, 
promoted a strong reduction in food consumption (Fig. 
5a and b) which was accompanied by high levels of 
STAT3 phosphorylation in the hypothalamus of middle-
aged rats (Fig. 5c and d). It was not found difference in 
body weight (data not shown). No difference was found 
in the levels of hypothalamic Akt phosphorylation after 
S1P injection (Fig. 5c), suggesting that S1PR1 induces 
the anorexigenic signal using leptin but not canonical 
insulin signaling.  
 
However, one could argue that the anorexigenic effects 
observed after pharmacological stimulation of 
hypothalamic S1PR1 could be related to the non-
physiological concentration of S1P, and/or by the 
toxicity mediated by SEW2871 in the central nervous 
system. To address this issue, we obtained the 
physiological levels of S1P from the cerebrospinal fluid 
(CSF) of young rats at rest and immediately after the 
acute exercise protocol. Surprisingly, we first observed 
that this acute exercise markedly increased S1P levels in 
the CSF of young rats (Fig. 5e). When the CSF of 
young, at rest mice was injected into middle-aged rats, 
we observed reduced food consumption by about 50% 
in middle-aged rats. Thereafter, we used the CSF from 
exercised rats with very high levels of S1P, and we 
observed that the ICV injection of CSF from exercised 
animals into middle-aged rats promoted a strong 
anorexigenic effect (Fig. 5f), suggesting that 
physiological concentrations of S1P mediates a potent 
anorexigenic signal. 
 
DISCUSSION 
 
In the present study, we investigated the role of the 
S1P/S1PR1 axis in the control of energy homeostasis of 
middle-aged rodents. Initial findings revealed that 
middle-aged rats had higher adipose levels compared to 
younger rats, as well as a strong reduction in energy 
expenditure, low UCP1 expression and change in the 
color of BAT. BAT plays a key role in thermogenesis 
and energy homeostasis in rodents and humans, through 
UCP1 [2-4]. Several studies have shown that low 
expression of UCP1 can cause several metabolic 
diseases such as obesity, type II diabetes and diseases 
related to age [3, 8]. Furthermore, it was shown that the 
activity and mass of BAT are higher in younger people 
or female individuals. Strong evidence reports that the 
impact of activity, BAT mass and consequently 
increased adiposity are diminished in the elderly [7]. In 
addition, while this decrease was found in females with 
increasing age, the strongest effects were found in older 
males [7].  
 
A decrease in the consumption of O2, release CO2, and 
RER during the dark cycle were also observed in 
middle-aged rats. A reduction in RER suggests that this 
group consumed more carbohydrates and fat, which 
were used as an energy [35]. We also observed a robust 
reduction in S1PR1 protein levels and STAT3 
phosphorylation in the hypothalamus of two different, 
middle-aged animal models. Taken together, these data 
suggest that, at least in part, defective anorexigenic and 
thermogenic signaling in middle-aged rodents could be 
associated with an impairment in hypothalamic 
S1PR1/STAT3 signaling. 
 
S1P synthesis occurs by phosphorylation of 
sphingosine, a reaction which is catalyzed by the 
sphingosine kinases, SphK1 and SphK2. S1P mediates 
its biological effects via paracrine or autocrine 
mechanisms [14]. Under pathological conditions, Liang 
et al. showed that aberrant levels of S1P occurs through 
up-regulation of SphK1 in cancer cells, which 
contributes to  inflammation and the progression of 
colon cancer [17]. Moreover, this change in S1P 
synthesis resulting in high serum S1P levels was 
observed in obese animal models [36, 37] as well as in 
obese individuals [38]. Based on these studies, we 
postulate that exercise could be a strong physiological 
modulator of S1P/S1PR1/STAT3 signaling, and that 
modulation of this axis can occur through two different 
mechanisms. The first is that acute exercise can increase 
circulating S1P levels, the second is that chronic 
exercise can restore hypothalamic levels of S1PR1 in 
middle-aged mice. However, the mechanisms by which 
exercise modulates S1P levels and hypothalamic S1PR1 
expression are unknown and deserves further 
investigation.  
 
Many aging-related diseases are linked to inflammatory 
processes [39-42]. Consistent with this notion, IL-6 an 
inflammatory cytokine has been reported to cause 
human prostate cancer, and is associated with morbidity 
and mortality when there are increased levels [42-46]. 
In the present study, chronic physical exercise was able 
to reduce circulating levels of IL-6 when compared to 
the sedentary middle-aged group. Conversely, acute 
exercise increased the IL-6 levels without statistical 
significance. These data led us to suspect that other 
circulating factor(s) are related to the anorexigenic and 
www.aging-us.com 149 AGING (Albany NY) 
thermogenic effects observed in exercising middle-aged 
rodents. It is important to mention that chronic and 
acute effects of exercise should be analyzed in distinct 
manners, as chronic exercise promotes several 
physiological adaptations, including changes in body 
composition, hormonal profile, anti-inflammatory 
response, and others [47, 48]. These significant 
alterations in the metabolism make the interpretation of 
some results difficult. For this reason, we decide to use 
an acute exercise protocol. The utilization of two 
different exercise protocols showed that chronic 
exercise had a robust effect on S1PR1 protein levels in 
the hypothalamus, when compared to acute exercise; 
however, acute exercise was sufficient to stimulate S1P 
levels.  
 
The effects of exercise on the control of food intake is a 
complex phenomenon and depends on many 
circumstances, including intensity, duration, type of 
exercise and especially the individuals enrolled in the 
exercise program. Recent studies have shown that 
exercise suppresses appetite in overweight and obese 
individuals [49-52], including adolescents and 
postmenopausal women [53]. However, the mechanism 
by which exercise modulates energy consumption is not 
clear. Other studies demonstrated that long term 
exercise induces the secretion of biomolecules derived 
from muscle including interleukins [54], apelin [55], 
acids and proteins rich in cysteine [56], and irisin [32] 
that promote the beneficial effects of exercise.  
 
Baranowske et al. demonstrated that acute exercise 
increases the level of S1P in plasma and erythrocyte 
ceramides of untrained subjects [22], while Banitalebi et 
al. showed that resistance training induces an increase 
in plasma levels of S1P with overexpression of its 
receptors S1PR1, S1PR2 and S1PR3 in the skeletal 
muscle of rats [25]. It appears that the plasma 
concentration of S1P only reaches high levels after 
performing high-intensity exercise, through increased 
production of sphingosine by skeletal muscle in humans 
[24]. There is some evidence supporting a key role of 
NPY in the control of hunger and energy expenditure 
during aging [57,58]. Here, we demonstrated that the 
physical exercise elicited the S1P/S1PR1/STAT3 axis, 
reduced NPY mRNA levels and that this phenomenon 
was associated with the energy intake and energy 
expenditure pattern observed in exercised middle-aged 
rats. The present study reports high levels of S1P in the 
CSF of young, exercised rats. When injected with CSF 
from either young rats at rest, or exercised young rats in 
middle-aged rats, noted that the anorexigenic effect it 
was increased, we believe that this are related to the 
amount of S1P contained in the CSF. However, it is 
important to note that high levels of S1P were found in 
hyperphagic mice, ob/ob [36]. This paradox can be 
explained by the strong downregulation of S1PR1 
expression observed in the hypothalamus of obese rats 
when compared to a lean group [21]. Likely, low levels 
of S1PR1 protein in the hypothalamus of obese animals 
is associated with deficient STAT3 signaling [59, 60], 
since STAT3 is a direct transcriptional activator of the 
promoter S1pr1 [20]. Interestingly, the expression of 
STAT3/S1PR1 as the S1P/S1PR1 axis is important for 
persistent phosphorylation of STAT3 results in a 
positive feedback circuit [20]. Thus, we believe that this 
similar mechanism occurs during aging, since the aging 
process leads to defective hypothalamic STAT3 activity 
[58].  
 
Upregulation of S1P levels in the CSF of exercised 
animals appears to be sufficient to normalize S1PR1 
protein levels in the hypothalamic tissue of aged 
rodents. S1PRs are composed of five subunits (S1PR1-
5) which activate several distinct signaling pathways in 
response to S1P [14]. Recently, we reported high levels 
of S1PR1 in the hypothalamus compared to various 
peripheral tissues. Importantly, S1PR1 and STAT3 are 
expressed in the same neuronal cells, confirming that 
crosstalk between S1P and leptin signaling occurs [21]. 
This information suggests that S1PR1 induces anorectic 
effects through STAT3 activity, since STAT3 controls 
the expression of anorexigenic in hypothalamic neurons 
[61]. In the present study we demonstrated that acute 
ICV injection of S1P induced STAT3 phosphorylation 
in the hypothalamus and reduced food intake in middle-
aged rats. Although S1P induced potent STAT3 
phosphorylation, S1P is not a specific S1PR1 activator. 
Thus, we performed an additional set of experiment by 
using a specific S1PR1 agonist (SEW2871), confirming 
the role of hypothalamic S1PR1 on STAT3 
phosphorylation. 
 
Lastly, our study showed that impairment of the 
S1PR1/STAT3 axis in the hypothalamus of middle-aged 
rodents was linked to defective anorexigenic and 
thermogenic signaling. In addition, we also show that 
physical exercise can increase S1P levels and restore the 
S1PR1/STAT3 hypothalamic in middle-aged rodents, 
increasing energy expenditure and food consumption.  
 
MATERIALS AND METHODS 
 
Animals and diet  
 
Wild-type mice (C57BL/6) and Wistar rats male were 
used. Mice were either young (2 months), or middle-
aged (12–15 months), and only old rats (24 months) 
were used. All animals were obtained from the 
University of Campinas Breeding Center. The project 
was approved by the ethics committee of the University 
of Campinas (number: 3137-1), which follows the 
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international university guidelines for the use of animals 
in experimental studies and experiments. All animals 
were maintained in a 12:12 hour light and dark cycle, 
and housed in cages between 22–24ºC. The light cycle 
started at 6:00 am. The animals were fed with a 
standard diet (3.948 kcal·kg-1) ad libitum. 
 
Intracerebroventricular Cannulation and Injection 
(ICV) 
 
Stereotactic surgery in Wistar rats was done as 
described previously [21]. S1P and SEW2871 injection: 
Rats were fasted for 10 hours prior to injection. For 
Western blot analysis, ICV of S1P (50 ng) and SEW (50 
nM) or respective vehicles were injected into the third 
ventricle. To evaluate the effects of S1P and SEW on 
STAT3 phosphorylation signaling, the hypothalamic 
tissue was removed 30 minutes later. To evaluate the 
effects of S1P and SEW on food intake and body weight 
in rats, ICV injections were all performed between 
5:00–6:00 p.m. CSF injection: CSF was obtained from 
Wistar rats at rest or immediately after acute exercise 
through the introduction of a needle into the cisterna 
magna through the skin and/or dura mater using a 
stereotactic micromanipulator, as previously described 
[62] with minor modifications.  Immediately after the 
liquor sampling, 2 µL of CSF or vehicle (saline) was 
injected into the third ventricle of middle-aged rats to 
evaluate food intake and body weight during 12 hour 
period. CSF injections were performed between 5:00–
6:00 p.m.  
 
Chronic exercise protocol (for mice) 
 
First, the mice were acclimated to swimming for two 
days, at ten minutes per day. Water temperature was 
maintained at 32 °C. The mice swam in groups of four 
in plastic barrels of 40 cm in diameter that were filled to 
a depth of 20 cm for one hour, during 5 days per four 
weeks. Cumulative food consumption and body weight 
measurements were made every day during the exercise 
protocol. Extraction of hypothalamic tissue was made 
after last (20th) session of the exercise protocol.  
 
Acute Exercise protocol (for rats) 
 
The Wistar rats exercised for only one session of acute 
swimming, as described previously [63]. The acute 
exercise protocol for rats were finished between 5:00–
6:00 p.m, for evaluation of food intake and body weight 
per 12 hour period and analysis of hypothalamic tissue. 
Samples of hypothalamic tissue were extracted after 
three hours of acute exercise.  
 
Dual energy X-ray absorptiometry (DXA scan) 
 
The mice were anaesthetized. The mensuration of body 
composition was evaluated in mice before and after 
chronical exercise protocol by Version 13.3:5 Rat 
Whole Body. Model: Discovery Wi (S/N 83901) by 
HOLOGIC Located in the Nuclear Medicine Service in 
the Hospital das Clínicas - Unicamp / Cidade 
Universitária Zeferino Vaz. SP-13083-888.   
 
BAT Imaging 
 
Images were taken immediately after extraction of 
BAT.  
 
Oxygen consumption determination 
 
The mice were acclimated for 24 hours to an open 
circuit calorimeter system, the LE405 Gas Analyzer 
(Panlab – Harvard Apparatus, Holliston, MA, USA), 
which was calibrated as recommended by the company 
and used to measure the rate of  O2 consumption, CO2 
production, RER, heat rate and ambulatory activity 
during the light and dark periods. Data was recorded for 
24 hours, and analyses were made between: young vs 
middle-aged mice, and middle-aged sedentary vs 
middle-aged exercised mice.  
 
Determination of S1P and IL6 levels 
 
For mice: Blood was collected from the cava vein 
following the last (20th) session of chronic exercise for 
mice. Plasma was separated by centrifugation (1,100 x 
g) for 15 minutes at 4 °C and stored at -80 °C until the 
assay. IL-6 concentrations were determined using a 
commercially available ELISA for mice, following the 
manufacturer’s instructions. For rats: three hours after 
acute exercise protocol, blood was collected from the 
cava vein. Plasma was separated by centrifugation 
(1,100 x g) for 15 min at 4 °C and stored at -80 °C until 
the assay. IL-6 concentrations were determined using a 
commercially available ELISA for rats, following the 
manufacturer’s instructions. CSF was obtained from 
young male rats at rest and exercised, and was extracted 
immediately after acute exercise protocol through the 
cisterna magna puncture using the stereotaxic apparatus. 
For serum and CSF S1P determination, we employed a 
commercially available S1P assay kit (Echelon 
Biosciences Inc.) 
 
Western blot analyses 
 
Three hours after acute exercise for rats, the 
hypothalamus was extracted. The animals were 
anesthetized and the hypothalamus quickly removed, 
minced coarsely, and homogenized immediately in a 
freshly prepared ice-cold buffer (1 % Triton X-100, 100 
mmol/L Tris pH 7.4, 100 mmol/L sodium 
pyrophosphate, 100 mmol/L sodium fluoride, 10 
mmol/L EDTA, 10 mmol/L sodium vanadate, 2 mmol/L 
www.aging-us.com 151 AGING (Albany NY) 
phenyl methylsulphonyl fluoride, and 0.1 mg aprotinin) 
suitable for preserving the phosphorylation state of 
enzymes. Proteins were separated by SDS-PAGE and 
transferred to nitrocellulose membranes. Specific 
antibodies (see below) and SuperSignalTM West Pico 
Chemiluminescent Substrate (Thermo Scientific) were 
used for protein analyses. The membranes uncut you 
can see in supplementary 4.  
 
Immunohistochemistry 
 
Paraformaldehyde-fixed rat hypothalami were sectioned 
(5 mm). The sections were obtained from the 
hypothalami of four rats per group in the same 
localization (antero–posterior = -1.78 from bregma) and 
were subjected to regular single- or double-
immunofluorescence staining using 4’,6-diamidino-2-
phenylindole, anti-EDG1(S1PR1), anti-pSTAT3, anti-
POMC. Analysis and photo documentation of results 
were performed using a LSM 510 laser confocal 
microscope (Zeiss, Jena, Germany). Anatomical 
correlations were made according to the landmarks 
given in a stereotaxic atlas.  
 
Antibodies and chemicals 
 
Anti-EDG-1 (rabbit polyclonal, SC-25489), anti-UCP1 
(goat polyclonal, M-17: SC-6529) antibodies were from 
Santa Cruz Biotechnology, Inc. anti-β Tubulin (rabbit 
polyclonal, #2146) anti-phospho-Akt (rabbit polyclonal, 
9271s) and anti-phospho-STAT3 (rabbit polyclonal, 
#9131), were from Cell Signaling Technology (Beverly, 
MA, USA). The antibody solution was 1:1000 for 
Western blots. Protein A-Sepharose 6 MB and 
nitrocellulose paper (Hybond ECL, 0.45 mm) were 
from Amersham Pharmacia Biotech United Kingdom 
Ltd. (Buckinghamshire, United Kingdom). S1P was 
from Avanti Polar Lipids Inc. (Alabama, EUA) and 
SEW2871 was from Cayman Chemical (Michigan, 
USA).   
 
mRNA Isolation and Real Time PCR 
 
Total hypothalamic RNA was extracted using Trizol 
reagent (Life Technologies, Gaithersburg, MD, USA), 
according to the manufacturer’s recommendations. 
Total RNA was isolated through DNA digestion with 
RNase-free DNase (RQ1, Promega, Madison, WI, 
USA). The BAT of mice was extracted after the last 
(20th) session of exercise for real time PCR analysis. 
Real time PCR and mRNA isolation were performed 
using commercial kits, following the manufacturer’s 
protocols: UCP1: Mm01244861_m1 and Mouse GAPD 
(GAPDH) Endogenous Control (Catalog 
number:  4352339E).  
 
The BAT and hypothalamus of rats were extracted after 
three hours exercise for real time PCR analyses. Real 
time PCR and mRNA isolation were performed using 
commercial kits, as follows: UCP1: - Rn00562126_m1, 
NPY: Rn00561681_m1 and Rat GAPD (GAPDH) 
Endogenous Control - Catalog number: 4352338E 
 
Statistical analysis 
 
All statistics were performed when necessary using the 
Student’s t test, with the Bonferroni posthoc test. 
Significance was established at the p<0.05 level. 
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